Global Cancer Biologics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Cancer Biologics Market Overview

• 1.1 Product Overview and Scope of Cancer Biologics
• 1.2 Classification of Cancer Biologics by Types
  • 1.2.1 Global Cancer Biologics Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Cancer Biologics Revenue Market Share by Types in 2018
  • 1.2.3 Monoclonal Antibodies
  • 1.2.4 Vaccines
  • 1.2.5 Cell and Gene Therapy
  • 1.2.6 Others
• 1.3 Global Cancer Biologics Market by Application
  • 1.3.1 Global Cancer Biologics Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Others
• 1.4 Global Cancer Biologics Market by Regions
  • 1.4.1 Global Cancer Biologics Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Cancer Biologics Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Biologics Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Biologics Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Cancer Biologics Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Biologics Status and Prospect (2014-2024)
• 1.5 Global Market Size of Cancer Biologics (2014-2024)

2 Manufacturers Profiles

• 2.1 Roche
  • 2.1.1 Business Overview
  • 2.1.2 Cancer Biologics Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Roche Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Novartis
  • 2.2.1 Business Overview
  • 2.2.2 Cancer Biologics Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Novartis Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Eli Lilly
  • 2.3.1 Business Overview
  • 2.3.2 Cancer Biologics Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Eli Lilly Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Sanofi
  • 2.4.1 Business Overview
  • 2.4.2 Cancer Biologics Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Sanofi Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Celgene
  • 2.5.1 Business Overview
  • 2.5.2 Cancer Biologics Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Celgene Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Pfizer
  • 2.6.1 Business Overview
  • 2.6.2 Cancer Biologics Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Pfizer Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Bayer
  • 2.7.1 Business Overview
  • 2.7.2 Cancer Biologics Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Bayer Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Johnson & Johnson
  • 2.8.1 Business Overview
  • 2.8.2 Cancer Biologics Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Johnson & Johnson Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Bristol-Myers Squibb
  • 2.9.1 Business Overview
  • 2.9.2 Cancer Biologics Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Bristol-Myers Squibb Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Merck
  • 2.10.1 Business Overview
  • 2.10.2 Cancer Biologics Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Merck Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Amgen
  • 2.11.1 Business Overview
  • 2.11.2 Cancer Biologics Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Amgen Cancer Biologics Revenue, Gross Margin and Market Share (2017-2018)

3 Global Cancer Biologics Market Competition, by Players

• 3.1 Global Cancer Biologics Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Cancer Biologics Players Market Share
  • 3.2.2 Top 10 Cancer Biologics Players Market Share
• 3.3 Market Competition Trend

4 Global Cancer Biologics Market Size by Regions

• 4.1 Global Cancer Biologics Revenue and Market Share by Regions
• 4.2 North America Cancer Biologics Revenue and Growth Rate (2014-2019)
• 4.3 Europe Cancer Biologics Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Cancer Biologics Revenue and Growth Rate (2014-2019)
• 4.5 South America Cancer Biologics Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Cancer Biologics Revenue and Growth Rate (2014-2019)

5 North America Cancer Biologics Revenue by Countries

• 5.1 North America Cancer Biologics Revenue by Countries (2014-2019)
• 5.2 USA Cancer Biologics Revenue and Growth Rate (2014-2019)
• 5.3 Canada Cancer Biologics Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Cancer Biologics Revenue and Growth Rate (2014-2019)

6 Europe Cancer Biologics Revenue by Countries

• 6.1 Europe Cancer Biologics Revenue by Countries (2014-2019)
• 6.2 Germany Cancer Biologics Revenue and Growth Rate (2014-2019)
• 6.3 UK Cancer Biologics Revenue and Growth Rate (2014-2019)
• 6.4 France Cancer Biologics Revenue and Growth Rate (2014-2019)
• 6.5 Russia Cancer Biologics Revenue and Growth Rate (2014-2019)
• 6.6 Italy Cancer Biologics Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Cancer Biologics Revenue by Countries

• 7.1 Asia-Pacific Cancer Biologics Revenue by Countries (2014-2019)
• 7.2 China Cancer Biologics Revenue and Growth Rate (2014-2019)
• 7.3 Japan Cancer Biologics Revenue and Growth Rate (2014-2019)
• 7.4 Korea Cancer Biologics Revenue and Growth Rate (2014-2019)
• 7.5 India Cancer Biologics Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Cancer Biologics Revenue and Growth Rate (2014-2019)

8 South America Cancer Biologics Revenue by Countries

• 8.1 South America Cancer Biologics Revenue by Countries (2014-2019)
• 8.2 Brazil Cancer Biologics Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Cancer Biologics Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Cancer Biologics Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Cancer Biologics by Countries

• 9.1 Middle East and Africa Cancer Biologics Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Cancer Biologics Revenue and Growth Rate (2014-2019)
• 9.3 UAE Cancer Biologics Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Cancer Biologics Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Cancer Biologics Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Cancer Biologics Revenue and Growth Rate (2014-2019)

10 Global Cancer Biologics Market Segment by Type

• 10.1 Global Cancer Biologics Revenue and Market Share by Type (2014-2019)
• 10.2 Global Cancer Biologics Market Forecast by Type (2019-2024)
• 10.3 Monoclonal Antibodies Revenue Growth Rate (2014-2024)
• 10.4 Vaccines Revenue Growth Rate (2014-2024)
• 10.5 Cell and Gene Therapy Revenue Growth Rate (2014-2024)
• 10.6 Others Revenue Growth Rate (2014-2024)

11 Global Cancer Biologics Market Segment by Application

• 11.1 Global Cancer Biologics Revenue Market Share by Application (2014-2019)
• 11.2 Cancer Biologics Market Forecast by Application (2019-2024)
• 11.3 Hospitals Revenue Growth (2014-2019)
• 11.4 Clinics Revenue Growth (2014-2019)
• 11.5 Others Revenue Growth (2014-2019)

12 Global Cancer Biologics Market Size Forecast (2019-2024)

• 12.1 Global Cancer Biologics Market Size Forecast (2019-2024)
• 12.2 Global Cancer Biologics Market Forecast by Regions (2019-2024)
• 12.3 North America Cancer Biologics Revenue Market Forecast (2019-2024)
• 12.4 Europe Cancer Biologics Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Cancer Biologics Revenue Market Forecast (2019-2024)
• 12.6 South America Cancer Biologics Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Cancer Biologics Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology